F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

F18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a powerful tool to investigate the role of tumor metabolic activity and its suppression by therapy for cancer survival. As part of Total Therapy 3 for newly diagnosed multiple myeloma, metastatic bone survey, magnetic resonance imaging...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bartel, Twyla B., Haessler, Jeff, Brown, Tracy L. Y., Shaughnessy, John D., van Rhee, Frits, Anaissie, Elias, Alpe, Terri, Angtuaco, Edgardo, Walker, Ronald, Epstein, Joshua, Crowley, John, Barlogie, Bart
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2009
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744568/
https://ncbi.nlm.nih.gov/pubmed/19443657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-213280
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars